Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology

LAUSANNE, Switzerland & FRAMINGHAM, Mass.–(BUSINESS WIRE)–Galderma, the world’s largest independent dermatology company, and Sofregen Medical, Inc., a medical device company pioneering the use of silk protein for tissue building and regeneration, announced today they have signed a co-development and option-to-acquire agreement. This collaboration will further expand Galderma’s capabilities built on decades of science-based aesthetics innovation […]

Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies

Share on twitter Share on linkedin MENLO PARK, Calif. and BILLERICA, Mass., Sept. 23, 2021 /PRNewswire/ — Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies, a provider of next generation sensors and analytics for real-time, in-process monitoring and analysis in upstream and downstream bioprocessing […]